
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
ARTMS specializes in the physics, chemistry and materials science of cyclotron-produced radionuclides. Our core technology platform, the QUANTM Irradiation SystemTM (QISTM), is a complete cyclotron-based isotope production system designed to support high efficiency, large-scale and cost-effective production of commercially important medical isotopes such as zirconium-89 (89Zr), gallium-68 (68Ga), technetium99m (99mTc) and copper-64 (64Cu). QISTM is used today by many of the major manufacturing networks to optimize production of a range of medical radioisotopes. ARTMS has been acquired by Telix Pharmaceuticals. Interested in joining the team? Search our open positions: https://telixpharma.com/careers/find-a-job
Radiopharmaceuticals,technetium-99m,cyclotron,biomedical,gallium-68,copper-64,zirconium-68,nuclear medicine,oncology,cardiology,neurology,and medical isotopes
Artms operates in the Pharmaceutical manufacturing industry.
Artms's revenue is 11m - 100m
Artms has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.